收藏切换
The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia
收藏切换
Fei PAN, Mengting HU, Jiaqi GAN, Yun ZHANG, Mei LIU*
World Clinical Drug | 2025, 46(7) : 651 - 656
Less
收藏切换
World Clinical Drug | 2025, 46(7): 651-656
• Article •
The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia
Full
Fei PAN, Mengting HU, Jiaqi GAN, Yun ZHANG, Mei LIU*
Affiliations
  • Department of General Practice, Minhang Hospital Affiliated to Fudan University, Shanghai 201199, China
Published: 2025-07-10 doi: 10.13683/j.wph.2025.07.004
Outline
收藏切换
Objective

To observe the effect of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus(T2DM) complicated with sarcopenia.

Methods

A total of 90 middle-aged and elderly patients with T2DM complicated with sarcopenia admitted to the endocrinology department of our hospital from January 2022 to January 2024 were selected and randomly divided into the observation group and the control group by simple sorting method, with 45 cases in each group. Both groups received conventional treatment. The observation group was added with denosumab. Both groups were treated for 12 months, and relevant indicators were detected and recorded once every 3 months.

Results

Before treatment and 3 months after treatment, there were no significant differences in indicators such as limb skeletal muscle mass index, grip strength, and walking speed between the two groups(P>0.05). After 6 months of treatment, the aforementioned indicators in the observation group were significantly increased compared with those before treatment and the control group at the same time point(P<0.01). Before treatment, there was no significant difference in the levels of osteocalcin, procollagen type Ⅰ N-terminal propeptide and β-collagen degradation products between the two groups(P>0.05). After treatment and at 6 months of treatment, the aforementioned indicators in the observation group improved better than those in the control group before treatment and at the same time point(P<0.05).There was a significant difference in the incidence of adverse reactions between the two groups(P<0.05).

Conclusion

Denosumab can effectively improve the muscle strength of middle-aged and elderly patients with T2DM complicated with sarcopenia, promote bone formation, reduce bone resorption, and has a positive impact on patients.

denosumab  /  type 2 diabetes mellitus  /  sarcopenia  /  bone metabolism
潘飞, 胡梦婷, 干佳琦, 张芸, 刘梅. 地舒单抗对中老年2型糖尿病合并肌少症患者骨代谢指标影响. 世界临床药物, 2025 , 46 (7) : 651 -656 . DOI: 10.13683/j.wph.2025.07.004
Fei PAN, Mengting HU, Jiaqi GAN, Yun ZHANG, Mei LIU. The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia[J]. World Clinical Drug, 2025 , 46 (7) : 651 -656 . DOI: 10.13683/j.wph.2025.07.004
Year 2025 volume 46 Issue 7
44
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.07.004
  • Receive Date:2025-03-07
  • Online Date:2026-11-09
  • Published:2025-07-10
Article Data
Affiliations
History
  • Received:2025-03-07
Funding
Affiliations
    Department of General Practice, Minhang Hospital Affiliated to Fudan University, Shanghai 201199, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.07.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT